Recent Finacing
Recent Raise
AlgoTx is a Suresnes, France biotech developing ATX01, a topical treatment for complex pain; completed Phase 1 safety and preparing Phase 2 trials in CIPN and erythromelalgia (FDA fast-track/orphan).
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at AlgoTherapeutix.
